Resolution and Prevention of Feline Immunodeficiency Virus-Induced Neurological Deficits by Treatment with the Protease Inhibitor TL-3

In vivo tests were performed to assess the influence of the protease inhibitor TL-3 on feline immunodeficiency virus (FIV)-induced central nervous system (CNS) deficits. Twenty cats were divided into four groups of five animals each. Group 1 received no treatment, group 2 received TL-3 only, group 3...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Huitron-Resendiz, Salvador, de Rozières, Sohela, Sanchez-Alavez, Manuel, Bühler, Bernd, Lin, Ying-Chuan, Lerner, Danica L., Henriksen, Nicholas W., Burudi, Mboya, Fox, Howard S., Torbett, Bruce E., Henriksen, Steven, Elder, John H.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2004
נושאים:
Vaccines and Antiviral Agents
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC387718/
https://ncbi.nlm.nih.gov/pubmed/15078933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.78.9.4525-4532.2004
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים